| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_356e70374ab14bfdca89f60efcb84def |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-145555 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D489-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D499-897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2014-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a2e9975d2593b851cc7b60f6f335a6d |
| publicationDate |
2014-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014135397-A1 |
| titleOfInvention |
Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
| abstract |
The present invention provides compositions and methods for the targeted delivery, release and/or formation of a drug compound at a target site(s) within the body of an individual, such as a diseased and/or inflamed tissue in the body of the individual. These compositions may comprise a halogenated phenol ring cleavably linked to a core structure of a drug compound. Due to the variety of substituents that may be utilized in forming the different types of linkages, numerous examples of drug compounds linked to a halogenated phenol ring are proposed. The present invention further provides compositions comprising halogenated phenol starting compounds that do not undergo cleavage during a dehalogenation reaction to form a drug compound in a targeted tissue when administered to an individual. Methods of administering these non-cleaving compounds are further provided. |
| priorityDate |
2011-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |